Chinese Producer Of Abortion Pill Under Investigation

Law360, New York (January 31, 2008, 12:00 AM EST) -- A Chinese pharmaceutical giant is being questioned over the safety of controversial abortion pill RU-486, which it supplies to the United States, after the contamination of a different drug injured scores of cancer patients in China.

An estimated 200 Chinese cancer patients developed serious side effects, including paralysis, after using a tainted leukemia drug. The drugs were produced by manufacturer Shanghai Hualian, a subsidiary of Shanghai Pharmaceutical Group.

Chinese drug regulators have accused the pharmaceutical company of trying to cover up the contamination, which prompted the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.